| 28756702 |
Kirby Schwartzbauer |
2026-10-23 18:14:36.185
|
Benign Skin Lesion Removal (Excludes Actinic Keratosis, and Mohs) (A57162) - R4 - Effective October 1, 2015 |
| 30472325 |
James Marko |
2026-10-28 13:51:52.584
|
Digital Mental Health Treatment Device: Medicare Billing and Documentation Requirements |
| 30466886 |
James Marko |
2026-10-23 15:29:42.916
|
NCCI Policy Manual Reminder |
| 30474249 |
James Marko |
2026-10-29 13:48:29.896
|
Transcatheter Aortic Valve Replacement (TAVR) Coverage Updates |
| 30474560 |
Kirby Schwartzbauer |
2026-10-29 16:58:56.525
|
MLN Connects - October 29, 2026 |
| 30474198 |
James Marko |
2026-10-29 13:24:29.739
|
Billing and Coding: MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis (A60217) - R2 - Effective October 1, 2026 |
| 28735771 |
Kirby Schwartzbauer |
2026-10-23 18:14:57.051
|
Billing and Coding: MolDX: Blood Product Molecular Antigen Typing (A57376) - R5 - Effective October 1, 2024 |
| 30473957 |
James Marko |
2026-10-29 13:11:06.446
|
2026 Q4 MolDX CPT/HCPCS Billing and Coding Article Updates - Effective October 1, 2026 |
| 30474370 |
Kirby Schwartzbauer |
2026-10-29 16:31:34.624
|
Submit Correct Place of Service for Nursing Facility Services |
| 28654803 |
Kirby Schwartzbauer |
2026-10-23 18:14:09.948
|
Billing and Coding MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (A58726) - R19 - Effective August 1, 2024 |
| 30473754 |
James Marko |
2026-10-29 12:06:18.136
|
Billing and Coding: Temporary Nontherapeutic Ambulatory Cardiac Monitoring Devices (A60279) - R2 - Effective October 1, 2026 |
| 30474265 |
James Marko |
2026-10-29 13:48:31.184
|
Transcatheter Aortic Valve Replacement (TAVR) Coverage Updates |
| 28724299 |
Kirby Schwartzbauer |
2026-10-23 18:14:51.359
|
Billing and Coding: MolDX: bioTheranostics Cancer TYPE ID® Update (A54388) - R11 - Effective October 1, 2024 |
| 30472309 |
James Marko |
2026-10-28 13:51:51.592
|
Digital Mental Health Treatment Device: Medicare Billing and Documentation Requirements |
| 28609907 |
Kirby Schwartzbauer |
2026-10-23 18:14:40.886
|
Billing and Coding: Implantable Infusion Pumps for Chronic Pain (A55323) - R17 - Effective July 1, 2024 |
| 30473839 |
James Marko |
2026-10-29 12:10:24.384
|
Billing and Coding: Injections - Tendon, Ligament, and Ganglion Cyst (A57079) - R7 - Effective November 1, 2026 |
| 30473940 |
James Marko |
2026-10-29 13:11:00.474
|
2026 Q4 MolDX CPT/HCPCS Billing and Coding Article Updates - Effective October 1, 2026 |
| 30471049 |
James Marko |
2026-10-27 14:58:34.349
|
New NEE Course: Ambulatory Surgical Center (ASC) - Prior Authorization Process |
| 30474097 |
James Marko |
2026-10-29 13:15:12.9
|
Billing and Coding: MolDX: Proteomics Testing (A59641) - R15 - Effective October 1, 2026 |
| 30316301 |
James Marko |
2026-10-28 13:13:06.308
|
2026 CMS National Provider Enrollment Conference (NPEC) |
| 30473856 |
James Marko |
2026-10-29 12:10:27.331
|
Billing and Coding: Injections - Tendon, Ligament, and Ganglion Cyst (A57079) - R7 - Effective November 1, 2026 |
| 30474181 |
James Marko |
2026-10-29 13:24:27.917
|
Billing and Coding: MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis (A60217) - R2 - Effective October 1, 2026 |
| 30314284 |
James Marko |
2026-10-28 13:13:04.487
|
2026 CMS National Provider Enrollment Conference (NPEC) |
| 30466868 |
James Marko |
2026-10-23 15:29:41.284
|
NCCI Policy Manual Reminder |
| 28748825 |
Kirby Schwartzbauer |
2026-10-23 18:14:47.695
|
Billing and Coding: MolDX: BCR-ABL (A55600)- R5 - Effective September 19, 2024 |
| 28654947 |
Kirby Schwartzbauer |
2026-10-23 18:14:44.228
|
Billing and Coding: MolDX: Afirma™ Assay by Veracyte (A54358) Retirement - Effective July 28, 2024 |
| 30474382 |
Kirby Schwartzbauer |
2026-10-29 16:31:48.551
|
Submit Correct Place of Service for Nursing Facility Services |
| 30473771 |
James Marko |
2026-10-29 12:06:20.482
|
Billing and Coding: Temporary Nontherapeutic Ambulatory Cardiac Monitoring Devices (A60279) - R2 - Effective October 1, 2026 |
| 30474080 |
James Marko |
2026-10-29 13:15:11.44
|
Billing and Coding: MolDX: Proteomics Testing (A59641) - R15 - Effective October 1, 2026 |
| 30474572 |
Kirby Schwartzbauer |
2026-10-29 16:58:59.301
|
MLN Connects - October 29, 2026 |